# The Effect of SAAE on Ventricular Remodeling in PA Patients

> **NCT05501080** · NA · RECRUITING · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 112 (estimated)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **OTHER:** Super selective adrenal artery embolization
- **DRUG:** Spironolactone

## Key facts

- **NCT ID:** NCT05501080
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05501080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05501080, "The Effect of SAAE on Ventricular Remodeling in PA Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05501080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*